about
Diabetic cardiomyopathy: bench to bedsideHigh-mobility group box 1: an amplifier of stem and progenitor cell activity after strokeS100A8 and S100A9 in cardiovascular biology and diseaseManufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cellsERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cellsAssociation of RAGE gene Gly82Ser polymorphism with coronary artery disease and ischemic stroke: A systematic review and meta-analysis.Genetic determinants of arterial stiffness.Controlling the receptor for advanced glycation end-products to conquer diabetic vascular complicationsCo-expression of BirA with biotin bait achieves in vivo biotinylation of overexpressed stable N-glycosylated sRAGE in transgenic silkworms.Lifestyle and Advanced Glycation End Products (AGEs) Burden: Its Relevance to Healthy AgingDysfunction of annexin A2 contributes to hyperglycaemia-induced loss of human endothelial cell surface fibrinolytic activityResearch resource: Aorta- and liver-specific ERα-binding patterns and gene regulation by estrogen.Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels.Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways.Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery diseaseOxidative stress and susceptibility to mitochondrial permeability transition precedes the onset of diabetes in autoimmune non-obese diabetic mice.C-reactive protein stimulates RAGE expression in human coronary artery endothelial cells in vitro via ROS generation and ERK/NF-κB activation.Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice.Regulation of RAGE for attenuating progression of diabetic vascular complications.Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 DiabetesSmall interfering RNA targeting receptor for advanced glycation end products suppresses the generation of proinflammatory cytokines.Skin Autofluorescence in Systemic Sclerosis Is Related to the Disease and Vascular Damage: A Cross-Sectional Analytic Study of Comparative GroupsUrinary biomarkers of oxidative status.Ameliorating Effect of Akebia quinata Fruit Extracts on Skin Aging Induced by Advanced Glycation End Products.Unique vascular protective properties of natural products: supplements or future main-line drugs with significant anti-atherosclerotic potential?Biochemical markers of aging for longitudinal studies in humans.Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fatα-Lipoic acid attenuates cardiac fibrosis in Otsuka Long-Evans Tokushima Fatty rats.RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice.Metabolic dysfunction in diabetic cardiomyopathy.IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.Biological functions of histidine-dipeptides and metabolic syndrome.Transforming dietary peptides in promising lead compounds: the case of bioavailable carnosine analogs.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.C-Peptide and its career from innocent bystander to active player in diabetic atherogenesis.Advanced glycation end-products: a common pathway in diabetes and age-related erectile dysfunction.Anti-diabetic effects of the Indian indigenous fruit Emblica officinalis Gaertn: active constituents and modes of action.Endothelial dysfunction in metabolic and vascular disorders.Advanced Glycation End Products, Inflammation, and Chronic Metabolic Diseases: Links in a Chain?
P2860
Q26997062-A15F63CC-2D5C-477F-95A6-43CBEFC5C233Q27008225-75EC4CEE-1085-489D-A8F6-3318F708C5E0Q27024450-21386B82-EB3F-4FD0-9EDE-8EA5B44E6611Q28388340-1DD75150-3278-4071-8475-C9B6898C2C94Q28574192-74F5B32B-A873-4374-B586-4F029028CD24Q30240149-CAD93421-77C1-4728-953F-FF2AA1A69D8CQ30301168-47340A49-079D-47D8-AC24-02F1CCBB9711Q33609776-AF6CCC43-8D37-42E4-9CCD-0785E4F3549FQ33671771-D48B6E3B-41C6-444D-8837-BCFC8BE601B4Q33680171-F02AB80B-A714-4792-854A-9D367AED88A1Q33789283-BB973271-64C5-403B-AFE7-3ED12C30A4F6Q33977389-BCE3354A-E17A-4F7C-AA5D-9E69B6A4E3E4Q34493878-EF4371CC-1F85-4E48-9AFB-F385DE8D4367Q34776889-4D1F00A3-05A9-43C3-B681-E780E1A670EEQ35240672-189A77E2-C93C-439C-A15B-E895568E27F2Q35263548-7439365A-7526-4E7E-81F3-183C6EDFE088Q35289480-2C4C2C9F-9A64-49C0-BF98-FAEB07EF873DQ35350451-6C17E3EE-E938-44AF-AE83-03A632ABA0A7Q35494903-71F64E2F-B600-4AFE-A7C1-F46E9497E35FQ35760856-C8ABEC8A-36E8-4342-95D3-838C36AB22A6Q35870539-D2AF2081-2710-4FB9-8F5B-DC68438DA5EAQ35924733-20D60F92-BC3E-4724-9974-744AE0188223Q36178739-A93D3E51-957A-4AAF-B3B7-58249E780C9FQ36329915-8EF49F2D-EB5A-44F7-B1F8-AF104426316DQ36429790-C90C807E-8BA0-46E7-BA4D-81218BBD2E9CQ36449881-15F085D3-1F18-4BDD-9405-59C5321680A9Q36458415-F074E5B9-1749-44A9-8560-4585C449F1B7Q36571926-E6F54C60-1F31-4936-B8BA-2B11FF568B00Q36635410-9D9584C8-512A-41E4-B239-1C5D42DEEF69Q36930481-D61058F3-61A4-4196-BA2B-FBCC761BC312Q37305013-96340547-8653-4A40-8F21-E18F1622470EQ37382495-BF39D569-6F98-452B-BF51-8CB9B73C6903Q37620472-14466E51-CD2B-4FED-898A-43FB013BB167Q37979691-44DC7D61-CCA3-4E19-9B7D-FF1E784AEEA2Q38096444-438BA1AE-341D-4D74-861F-7CCB1A11192CQ38112357-2748C662-2E7E-4951-A52D-F0019E3E396FQ38118993-D5B5D40E-E186-4F2D-87BB-CFB278CB6274Q38191793-476D34AC-67E8-4E18-B80A-FF1EC7673348Q38200828-58661AF3-6435-43C6-BDB2-F58AC8DED02BQ38254631-CA941E1F-0C35-4E86-8EA4-789E9D678A00
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
RAGE biology, atherosclerosis and diabetes.
@en
RAGE biology, atherosclerosis and diabetes.
@nl
type
label
RAGE biology, atherosclerosis and diabetes.
@en
RAGE biology, atherosclerosis and diabetes.
@nl
prefLabel
RAGE biology, atherosclerosis and diabetes.
@en
RAGE biology, atherosclerosis and diabetes.
@nl
P2093
P2860
P356
P1433
P1476
RAGE biology, atherosclerosis and diabetes.
@en
P2093
Aino Soro-Paavonen
Drazenka Pongrac Barlovic
Karin A M Jandeleit-Dahm
P2860
P356
10.1042/CS20100501
P407
P577
2011-07-01T00:00:00Z